Vitamin D serum level predicts stroke clinical severity, functional independence, and disability-A retrospective cohort study
- PMID: 35968390
- PMCID: PMC9363625
- DOI: 10.3389/fnins.2022.951283
Vitamin D serum level predicts stroke clinical severity, functional independence, and disability-A retrospective cohort study
Abstract
Background: Stroke is a leading cause of mortality and disability and one of the most common neurological conditions globally. Many studies focused on vitamin D as a stroke risk factor, but only a few focused on its serum level as a predictor of stroke initial clinical severity and recovery with inconsistent results. The purpose of this study was to assess the relationship between serum vitamin D levels and stroke clinical severity at admission and functional independence and disability at discharge in Saudi Arabia.
Methodology: A retrospective cohort study of adult ischemic stroke patients who had their vitamin D tested and admitted within 7 days of exhibiting stroke symptoms at King Abdulaziz Medical City (KAMC) Jeddah, Saudi Arabia. Based on vitamin D level, the patients were categorized into normal [25(OH)D serum level ≥ 75 nmol/L], insufficient [25(OH)D serum level is 50-75 nmol/L], and deficient [25(OH)D serum level ≤ 50 nmol/L]. The primary outcome was to assess the vitamin D serum level of ischemic stroke patients' clinical severity at admission and functional independence at discharge. The National Institute of Health Stroke Scale (NIHSS) was used to assess the clinical severity, whereas the modified Rankin scale (mRS) was used to assess functional independence and disability.
Results: The study included 294 stroke patients, out of 774, who were selected based on the inclusion and exclusion criteria. The mean age of the participants was 68.2 ± 13.4 years, and 49.3% were male. The patients' distribution among the three groups based on their vitamin D levels is: normal (n = 35, 11.9%), insufficient (n = 66, 22.5%), and deficient (n = 196, 65.6%). After adjusting for potential covariates, regression analysis found a significant inverse relationship of NIHSS based on 25(OH)D serum level (beta coefficient: -0.04, SE: 0.01, p = 0.003). Patients with deficient serum vitamin D level also had significantly higher odds of worse functional independence in mRS score [OR: 2.41, 95%CI: (1.13-5.16), p = 0.023] when compared to participants with normal vitamin D level.
Conclusion: Low vitamin D levels were associated with higher severity of stroke at admission and poor functional independence and disability at discharge in patients with acute ischemic stroke. Further randomized clinical and interventional studies are required to confirm our findings.
Keywords: 25(OH)D; NIHSS score; disability; modified Rankin scale (mRS); prevention; recovery; stroke; vitamin D.
Copyright © 2022 Alharbi, Alali, Samman, Alghamdi, Albaradie, Almaghrabi, Makkawi, Alghamdi, Alzahrani, Alsalmi, Karamyan, Al Sulaiman, Aljuhani and Alamri.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke.Cerebrovasc Dis. 2015;40(1-2):73-80. doi: 10.1159/000434691. Epub 2015 Jul 11. Cerebrovasc Dis. 2015. PMID: 26184826
-
Patients with moderate to severe strokes (NIHSS score >10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes.J Vasc Surg. 2019 May;69(5):1471-1481. doi: 10.1016/j.jvs.2018.07.079. Epub 2019 Jan 8. J Vasc Surg. 2019. PMID: 30635157
-
Impact of Vitamin D Deficiency on Ischemic Stroke Severity: Insights from a Prospective Study.Cureus. 2024 Sep 13;16(9):e69376. doi: 10.7759/cureus.69376. eCollection 2024 Sep. Cureus. 2024. PMID: 39403669 Free PMC article.
-
Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension.Neurochem Int. 2018 Sep;118:91-95. doi: 10.1016/j.neuint.2018.05.001. Epub 2018 May 3. Neurochem Int. 2018. PMID: 29729873
-
Vitamin D and Stroke: Effects on Incidence, Severity, and Outcome and the Potential Benefits of Supplementation.Front Neurol. 2020 Jun 10;11:384. doi: 10.3389/fneur.2020.00384. eCollection 2020. Front Neurol. 2020. PMID: 32587562 Free PMC article.
Cited by
-
A multicenter analysis to identify the risk factors for stroke recurrence and mortality within 1 year.Front Neurol. 2025 Feb 5;16:1478175. doi: 10.3389/fneur.2025.1478175. eCollection 2025. Front Neurol. 2025. PMID: 40040911 Free PMC article.
-
Vitamin D supplementation in later life: a systematic review of efficacy and safety in movement disorders.Front Aging Neurosci. 2024 Jan 26;16:1333217. doi: 10.3389/fnagi.2024.1333217. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38343878 Free PMC article.
-
Insights into risk factors and outcomes of post-stroke seizures in Saudi Arabia: a multicenter analysis.Metab Brain Dis. 2024 Dec 19;40(1):72. doi: 10.1007/s11011-024-01508-3. Metab Brain Dis. 2024. PMID: 39699699 Free PMC article.
-
Assessing the effects of antidepressant use on stroke recurrence and related outcomes in ischemic stroke patients: a propensity score matched analysis.Front Pharmacol. 2025 Mar 12;16:1558703. doi: 10.3389/fphar.2025.1558703. eCollection 2025. Front Pharmacol. 2025. PMID: 40144654 Free PMC article.
-
Efficacy of Oral Supplementation with Cholecalciferol Versus Calcifediol in Patients with Hypovitaminosis D After Stroke.Nutrients. 2025 Mar 15;17(6):1035. doi: 10.3390/nu17061035. Nutrients. 2025. PMID: 40292472 Free PMC article.
References
-
- Al Shoyaib A., Alamri F. F., Biggers A., Karamyan S. T., Arumugam T. V., Ahsan F., et al. (2021a). Delayed Exercise-induced Upregulation of Angiogenic Proteins and Recovery of Motor Function after Photothrombotic Stroke in Mice. Neuroscience 461 57–71. 10.1016/j.neuroscience.2021.02.023 - DOI - PMC - PubMed
-
- Alamri F. F., Al Shoyaib A., Syeara N., Paul A., Jayaraman S., Karamyan S. T., et al. (2021). Delayed atomoxetine or fluoxetine treatment coupled with limited voluntary running promotes motor recovery in mice after ischemic stroke. Neural Regen. Res. 16 1244–1251. 10.4103/1673-5374.301031 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources